Stomatitis Management and Treatment-Related Toxicity

Dr. Bouberhan initiates discussion of treatment-related side effects, particularly stomatitis management strategies for patients receiving nab-sirolimus or everolimus. Dr. Choy acknowledges extensive experience managing mouth sores across various sarcoma treatments, implementing comprehensive oral hygiene protocols as foundational care.

Standard preventive measures include twice-daily brushing and flossing with gentle toothpaste to minimize oral irritation. For nab-sirolimus specifically, where mouth sores occur commonly, patients receive recommendations for baking soda or warm salt water rinses performed 2 to 3 times daily, which adequately controls symptoms for many patients. An innovative though unproven technique involves ice chip mouth cooling during infusions, theoretically causing vasoconstriction to reduce chemotherapy delivery to oral mucosa. Although uncertain about mechanism effectiveness, some patients report symptomatic improvement in subsequent cycles.

Dr. Bouberhan discusses evidence-based stomatitis mitigation from non-PEComa literature, highlighting the SWISH trial investigating prophylactic dexamethasone mouthwash in patients with breast cancer receiving everolimus plus exemestane combination therapy. The intervention involved dilute dexamethasone elixir swished for 2 minutes 4 times daily during the first 8 treatment weeks, demonstrating marked stomatitis reduction from 39% grade 2 or higher in controls to only 2% in the intervention group.

However, dexamethasone rinses carried side effects including hyperglycemia from routine steroid exposure. Dr. Choy indicates infrequent steroid mouthwash prescription in his practice, preferring Peridex (non-alcoholic chlorhexidine) for oral hygiene maintenance and nystatin mouthwash for Candida-associated mouth sores, with swallow instructions to address potential esophageal involvement.

Physical examination importance emerges through differential diagnosis considerations, as Dr. Bouberhan notes that inappropriate dexamethasone administration could worsen candidiasis. Dr. Choy shares a clinical case where presumed treatment-related stomatitis actually represented herpes simplex virus infection, resolving rapidly with valacyclovir therapy. This emphasizes that although stomatitis represents common mTOR inhibitor toxicity, clinicians must avoid automatic assumptions and perform appropriate evaluations.